Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.76

-2.1%

Dec 30 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tuck	10/13/2004 3:23:03 PM
	Read Replies (1) of 3722

Bernard, Hope you've come out of the final blows of the hurricane season OK. I am looking at MYGN as a short term trade here. One of the few biotechs that is above its 200 day MA. It touched it's 50 day today at what looks like a support area. I am wondering of this constitutes a good entry as well as stop loss level. Also long NBIX from ~$45.20. Like the action so far, and target is $50 unless the NAZ gives me the willies (and it has me worried). Finally, I think ARQL and TELK are fundamentally buys, with ARQL near good technical support, but with TELK vulnerable to $18 or so (rokoko's target of $10 (given in the REGN thread) seems very unlikely to me on fundamental grounds). Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next